Long Read Sequencing Market to Grow with a CAGR of 20.28% through 2030

Growing R&D activities and rising government support to drive the long read sequencing market in the forecast period, 2026-2030.

According to TechSci Research report, “Long Read Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030”, the Global Long Read Sequencing Market was valued at USD 610.27 million in 2024 and is expected to reach USD 1847.24 million by 2030 with a CAGR of 20.28% during the forecast period. The growing occurrences of genetic disorders, the growing government support for R&D activities, and increase in adoption of advanced technologies are the primary factors driving the demand for the global long read sequencing market. The growing number of patients with cancer, rise in R&D activities, rising popularity of personalized medicine, growing favorable government funding, increasing healthcare expenditure, and growing adoption of inorganic growth strategies are expected to influence the market demand. Also, the rising utilization of sequence analysis methodologies in medical institutes for academic purposes are also a key factor for increasing the growth of the long read sequencing market, globally.
However, the lack of high complexity genomic testing centers in high potential markets, challenges pertaining to genomic data centers, and scarcity of knowledge dissemination pertaining to advanced diagnostic capabilities may hamper the growth of the global Long Read Sequencing market.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Long Read Sequencing Market"

The global long read sequencing market is segmented into component, technology, workflow, application, end user, regional distribution and company.

Based on Technology, the nanopore sequencing segment shows the fastest growth under the technology category. Nanopore sequencing has gained significant momentum in recent years due to its portability, scalability, lower cost per run, and ability to generate ultra-long reads in real time. Unlike single-molecule real-time (SMRT) sequencing, which often requires large, sophisticated instruments and controlled laboratory setups, nanopore sequencing devices can be as small as a handheld unit, such as the Oxford Nanopore Technologies’ MinION, making them highly adaptable for both clinical and field-based applications. One of the strongest drivers for the rapid adoption of nanopore sequencing is its real-time data generation capability, which is particularly crucial for clinical diagnostics, pathogen surveillance, and outbreak management. For example, during the COVID-19 pandemic, nanopore sequencing was widely used to rapidly sequence SARS-CoV-2 genomes across multiple countries, enabling real-time tracking of viral mutations and supporting public health interventions. Governments and international agencies, including the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), recognized nanopore sequencing as a critical tool for pandemic genomic surveillance. Its speed, portability, and relatively low infrastructure requirements made it highly suitable for both developed and resource-limited regions.

Based on the Region, the Asia-Pacific region is expected to show the fastest growth over the coming years. This growth is largely fueled by rising investments in genomics, expanding healthcare infrastructure, and increasing government initiatives across countries such as China, Japan, India, South Korea, and Australia. For instance, China’s “Precision Medicine Initiative”, launched with a budget of over USD 9 billion for 2016–2030, is one of the largest government-funded programs focused on genomics and personalized medicine. Similarly, Japan’s Moonshot Research and Development Program and India’s GenomeIndia project, which aims to sequence 10,000 genomes of its citizens, are accelerating advancements in genomic research. These initiatives provide a strong foundation for the adoption of long read sequencing technologies in clinical diagnostics, cancer research, and rare disease detection. The region is also experiencing rapid population growth and a high prevalence of chronic and genetic diseases, which necessitate better diagnostic tools. According to the World Health Organization (WHO), Asia accounts for nearly 60% of the global population and faces a rising burden of diseases such as cancer, with over 9.5 million new cancer cases reported in Asia in 2020. The demand for more accurate sequencing technologies like long read sequencing is therefore increasing, as they can capture complex genomic variations more effectively than traditional short read methods. Furthermore, Asia-Pacific is witnessing a surge in collaborations between global sequencing companies and local research institutes, helping to expand accessibility and reduce costs.

Major companies operating in Global Long Read Sequencing Market are:

• Agilent Technologies, Inc.
• BGI Group
• Bionano Genomics, Inc.
• Circulomics Inc
• Oxford Nanopore Technologies plc
• Longas Technologies Pty Ltd
• Novogene Co., Ltd.
• Illumina, Inc.
• F. Hoffmann-La Roche AG
• Pacific Biosciences of California, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“North America region dominates the market and is expected to maintain its dominance in the coming years due to adoption of the latest technology and rising utilization of long-read sequencing techniques across medical diagnostic centers. The upsurge in research and development activities, the availability of strong reimbursement policies from public and private health insurance firms, favorable government initiatives in the healthcare sector, and growing academic and clinical use of genomic techniques in the region are expected to propel the global long read sequencing market growth” said Mr. Karan Chechi, Research Director of TechSci Research, a research based global management consulting firm.

“Long Read Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Instruments, Consumables, Services), By Technology (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing, Others), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By Application (Oncology, Infectious Diseases, Rare Diseases, Genetic Disorders, Metabolic Disorders, Others), By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of global long read sequencing market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global long read sequencing market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com